title: Reply from Lasse Gliemann, Jakob Schmidt, Jesper Olesen, Rasmus Sjørup Biensø, Sebastian Louis Peronard, Simon Udsen Grandjean, Stefan Peter Mortensen, Michael Nyberg, Jens Bangsbo, Henriette Pilegaard and Ylva Hellsten.
authors.affiliation: yhellsten@ifi.ku.dk.
authors.forename: Lasse
authors.initials: L
authors.lastname: Gliemann
authors.forename: Jakob
authors.initials: J
authors.lastname: Schmidt
authors.forename: Jesper
authors.initials: J
authors.lastname: Olesen
authors.forename: Rasmus Sjørup
authors.initials: RS
authors.lastname: Biensø
authors.forename: Sebastian Louis
authors.initials: SL
authors.lastname: Peronard
authors.forename: Simon Udsen
authors.initials: SU
authors.lastname: Grandjean
authors.forename: Stefan Peter
authors.initials: SP
authors.lastname: Mortensen
authors.forename: Michael
authors.initials: M
authors.lastname: Nyberg
authors.forename: Jens
authors.initials: J
authors.lastname: Bangsbo
authors.forename: Henriette
authors.initials: H
authors.lastname: Pilegaard
authors.forename: Ylva
authors.initials: Y
authors.lastname: Hellsten
mesh_terms: D002319:Cardiovascular System / Q000187:drug effects*; D015444:Exercise; D006801:Humans; D008297:Male; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology*
chemical_list: D013267:Stilbenes; D000077185:Resveratrol